Although Citi continues to give 0809.HK a buy / moderate risk rating, the list price is only HK $2.04, saying that although its first-half results showed a red of HK $91 million, its management is still positive for the second half of the year, and is looking forward to an improvement in the operating environment and higher product prices. It does not expect capacity expansion next year.

Dacheng biochemical fell 0.96% to HK $2.0 on Friday.